Can-Fite BioPharma Ltd. SEC Filing (Oct 13, 2026)

2 SOURCES CONFIRMED · FIRST SEEN 2026-10-13 11:12 UTC · LAST UPDATE 2026-10-13 11:48 UTC

KINDNews

DIRECTION■ Unclear/unknown

SOURCES2

ENTITIES0

STORY SIZESTANDALONE

FIRST SEEN2026-10-13 11:12 UTC

LAST UPDATE2026-10-13 11:48 UTC

STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Routine SEC filing for a small biopharma; headline carries no financial or clinical substance to price.

Routine filing, no actionable signal

CATALYST TO WATCH

Contents of the filing when read

MAIN RISK

Possible undisclosed dilution or trial news

02 THE STORY SO FAR

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

NO ENTITY LINKS AT DISPLAY CONFIDENCE YET.

04 RECEIPTS

2 SOURCES CONFIRMED

№ 01googlenewsnews.google.com · CONFIRMING2026-10-13 11:48 UTCOPEN RECEIPT →

№ 02googlenewsnews.google.com · PRIMARY2026-10-13 11:12 UTCOPEN RECEIPT →

05 PROPAGATION

NO LINKED INTELLIGENCE YET.

KEEP READING THE MACHINE

Summaries are generated and may contain errors — every claim links its sources.